Internal Medicine, Rheumatology · Kansas City, MO
NPI
1194739227
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4440 Broadway Blvd Ste 40
Kansas City, MO, 64111
Phone (816) 531-0930
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
225,528 services
Medicare patients, 2024
732
Average age 73
Drug cost, 2024
$2.2M
5,609 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kent K Huston was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 123,600 times for 34 patients. In total Kent K Huston billed 225,528 services in 109 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 123,600 | 34 | $3.61 | $446K |
| J3262 Injection, tocilizumab, 1 mg | Office | 32,400 | 22 | $4.69 | $152K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 15,560 | 79 | $0.10 | $1,599 |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,050 | 25 | $9.03 | $91K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,450 | 46 | $33.46 | $316K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 5,320 | 46 | $24.34 | $130K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,580 | 19 | $36.33 | $130K |
| J0897 Injection, denosumab, 1 mg | Office | 2,580 | 26 | $20.71 | $53K |
| J9312 Injection, rituximab, 10 mg | Office | 2,290 | 18 | $61.08 | $140K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,417 | 21 | $0.23 | $320 |
| 36415 Venipuncture Blood Collection | Office | 1,117 | 455 | $8.60 | $9,611 |
| 86140 Clinical Chemistry | Office | 1,005 | 430 | $5.03 | $5,058 |
| 85025 Blood Count | Office | 979 | 404 | $7.54 | $7,386 |
| 99214 Office E&M - Established | Office | 898 | 460 | $83.18 | $75K |
| 82565 Clinical Chemistry | Office | 862 | 354 | $4.98 | $4,289 |
By year: 2022 $1.5M for 159,028 services; 2023 $1.8M for 198,099 services; 2024 $2.1M for 225,528 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,117 | 455 | $8.60 | $9,611 |
| 86140 Clinical Chemistry | 1,005 | 430 | $5.03 | $5,058 |
| 85025 Blood Count | 979 | 404 | $7.54 | $7,386 |
| 82565 Clinical Chemistry | 862 | 354 | $4.98 | $4,289 |
| 80076 Clinical Chemistry | 860 | 354 | $7.94 | $6,827 |
| 84550 Clinical Chemistry | 161 | 103 | $4.41 | $710 |
| 82550 Clinical Chemistry | 156 | 98 | $6.35 | $990 |
| 80053 Clinical Chemistry | 142 | 90 | $10.29 | $1,461 |
| 85651 Clinical Chemistry | 112 | 89 | $4.18 | $468 |
| 81002 Clinical Chemistry | 90 | 51 | $3.35 | $301 |
Medicare prescription drug claims, 2024
In 2024, the drug Kent K Huston prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,356 prescriptions and refills. In total Kent K Huston wrote 5,609 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,356 | 2,704 | 304 | $56K |
| Methotrexate Methotrexate Sodium | 733 | 1,620 | 181 | $21K |
| Prednisone Generic | 476 | 796 | 131 | $3,049 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 270 | 270 | 37 | $9,875 |
| Leflunomide Generic | 243 | 573 | 71 | $13K |
| Sulfasalazine Dr Sulfasalazine | 225 | 429 | 56 | $12K |
| Tramadol Hcl Generic | 209 | 215 | 43 | $1,975 |
| Sulfasalazine Generic | 201 | 482 | 53 | $8,139 |
| Meloxicam Generic | 195 | 371 | 49 | $846 |
| Mycophenolate Mofetil Generic | 119 | 201 | 23 | $12K |
| Celecoxib Generic | 105 | 232 | 32 | $5,516 |
| Allopurinol Generic | 95 | 251 | 22 | $892 |
| Folic Acid Generic | 90 | 222 | 25 | $825 |
| Gabapentin Generic | 83 | 130 | 19 | $990 |
| Alendronate Sodium Generic | 80 | 210 | 31 | $514 |
Brand drugs: - claims; generic drugs: 4,913 claims; opioid claims: 521.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kent K Huston $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.